Heat shock proteins in ovarian cancer: A potential target for therapy

Gynecologic Oncology

Volumn 119, Issue 1, 2010, Pages 164-166

  Cohen, Marie ^a   Dromard, Mathilde ^a   Petignat, Patrick ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Heat shock proteins; Marker; Ovarian cancer

Indexed keywords

CANCER ANTIBODY; DOCETAXEL; HEAT SHOCK PROTEIN 10; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; OGX 427; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; HEAT SHOCK PROTEIN;

CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL TRIAL; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; HUMAN; IMMUNE RESPONSE; METASTASIS; MONOTHERAPY; MULTICENTER STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVIEW; TUMOR DIFFERENTIATION; DRUG DELIVERY SYSTEM; DRUG RESISTANCE; METABOLISM; OVARIAN NEOPLASMS; PROCEDURES;

DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; OVARIAN NEOPLASMS;

EID: 77956651448     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.05.027     Document Type: Review

References (46)

1. B.K. Edwards, M.L. Brown, P.A. Wingo, H.L. Howe, E. Ward, and L.A. Ries Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment J Natl Cancer Inst 97 2005 1407 1427
2. W.P. McGuire, W.J. Hoskins, M.F. Brady, P.R. Kucera, E.E. Partridge, and K.Y. Look Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N Engl J Med 334 1996 1 6
3. E.A. Craig Chaperones: helpers along the pathways to protein folding Science 260 1993 1902 1903
4. F.U. Hartl Molecular chaperones in cellular protein folding Nature 381 1996 571 579
5. A. Samali, J. Cai, B. Zhivotovsky, D.P. Jones, and S. Orrenius Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of Jurkat cells EMBO J 18 1999 2040 2048
6. S. Xanthoudakis, S. Roy, D. Rasper, T. Hennessey, Y. Aubin, and R. Cassady Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis EMBO J 18 1999 2049 2056
7. M. Zylicz, F.W. King, and A. Wawrzynow Hsp70 interactions with the p53 tumour suppressor protein EMBO J 20 2001 4634 4638
8. M. Jaattela, D. Wissing, K. Kokholm, T. Kallunki, and M. Egeblad Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases EMBO J 17 1998 6124 6134
9. A. Samali, and S. Orrenius Heat shock proteins: regulators of stress response and apoptosis Cell Stress Chaperones 3 1998 228 236
10. S. Arnaudeau, P. Arboit, P. Bischof, K. Shin-ya, A. Tomida, and T. Tsuruo Glucose-regulated protein 78: a new partner of p53 in trophoblast Proteomics 9 2009 5316 5327
11. S. Takayama, D.N. Bimston, S. Matsuzawa, B.C. Freeman, C. Aime-Sempe, and Z. Xie BAG-1 modulates the chaperone activity of Hsp70/Hsc70 EMBO J 16 1997 4887 4896
12. D. Tang, M.A. Khaleque, E.L. Jones, J.R. Theriault, C. Li, and W.H. Wong Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo Cell Stress Chaperones 10 2005 46 58
13. D.R. Ciocca, and S.K. Calderwood Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications Cell Stress Chaperones 2005 86 103
14. H.H. Wang, C.Y. Mao, L.S. Teng, and J. Cao Recent advances in heat shock protein-based cancer vaccines Hepatobiliary Pancreat Dis Int 5 2006 22 27
15. F. Cappello, F. Rappa, S. David, R. Anzalone, and G. Zummo Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis Anticancer Res 23 2003 1325 1331
16. F. Cappello HSP60 and HSP10 as diagnostic and prognostic tools in the management of exocervical carcinoma Gynecol Oncol 91 2003 661
17. F. Cappello, M. Bellafiore, S. David, R. Anzalone, and G. Zummo Ten kilodalton heat shock protein (HSP10) is overexpressed during carcinogenesis of large bowel and uterine exocervix Cancer Lett 196 2003 35 41
18. F. Cappello, M. Bellafiore, A. Palma, S. David, V. Marciano, and T. Bartolotta 60 kDa chaperonin (HSP60) is over-expressed during colorectal carcinogenesis Eur J Histochem 47 2003 105 110
19. S. Akyol, C. Gercel-Taylor, L.C. Reynolds, and D.D. Taylor HSP-10 in ovarian cancer: expression and suppression of T-cell signaling Gynecol Oncol 101 2006 481 486
20. B. Tetu, I. Popa, I. Bairati, S. L'Esperance, M. Bachvarova, and M. Plante Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas Mod Pathol 21 2008 1002 1010
21. E. Kimura, R.E. Enns, J.E. Alcaraz, J. Arboleda, D.J. Slamon, and S.B. Howell Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60 J Clin Oncol 11 1993 891 898
22. J. Schneider, E. Jimenez, K. Marenbach, H. Romero, D. Marx, and H. Meden Immunohistochemical detection of HSP60-expression in human ovarian cancer. Correlation with survival in a series of 247 patients Anticancer Res 19 1999 2141 2146
23. H.J. Arts, H. Hollema, W. Lemstra, P.H. Willemse, E.G. De Vries, and H.H. Kampinga Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis Int J Cancer 84 1999 234 238
24. G.O. Elpek, S. Karaveli, T. Simsek, N. Keles, and N.H. Aksoy Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries Apmis 111 2003 523 530
25. M.B. Elstrand, L. Kleinberg, E.C. Kohn, C.G. Trope, and B. Davidson Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma Int J Gynecol Pathol 28 2009 211 221
26. J.P. Geisler, H.E. Geisler, J. Tammela, M.C. Wiemann, Z. Zhou, and G.A. Miller Heat shock protein 27: an independent prognostic indicator of survival in patients with epithelial ovarian carcinoma Gynecol Oncol 69 1998 14 16
27. I. Germain, B. Tetu, J. Brisson, M. Mondor, and M.G. Cherian Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases Int J Gynecol Pathol 15 1996 54 62
28. S.P. Langdon, G.J. Rabiasz, G.L. Hirst, R.J. King, R.A. Hawkins, and J.F. Smyth Expression of the heat shock protein HSP27 in human ovarian cancer Clin Cancer Res 1 1995 1603 1609
29. B. Piura, A. Rabinovich, V. Yavelsky, and M. Wolfson Heat shock proteins and malignancies of the female genital tract Harefuah 141 2002 969 972 1010, 1009
30. J. Schneider, E. Jimenez, K. Marenbach, D. Marx, and H. Meden Co-expression of the MDR1 gene and HSP27 in human ovarian cancer Anticancer Res 18 1998 2967 2971
31. C.M. Annunziata, L. Kleinberg, B. Davidson, A. Berner, D. Gius, and N. Tchabo BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer Clin Cancer Res 13 2007 6585 6592
32. S.E. Conroy, P.D. Sasieni, I. Fentiman, and D.S. Latchman Autoantibodies to the 90 kDa heat shock protein and poor survival in breast cancer patients Eur J Cancer 34 1998 942 943
33. L.Y. Luo, I. Herrera, A. Soosaipillai, and E.P. Diamandis Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library Br J Cancer 87 2002 339 343
34. K. Nanbu, I. Konishi, T. Komatsu, M. Mandai, S. Yamamoto, and H. Kuroda Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression Cancer 77 1996 330 338
35. K. Nanbu, I. Konishi, M. Mandai, H. Kuroda, A.A. Hamid, and T. Komatsu Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas Cancer Detect Prev 22 1998 549 555
36. I. Korneeva, A.M. Bongiovanni, M. Girotra, T.A. Caputo, and S.S. Witkin IgA antibodies to the 27-kDa heat-shock protein in the genital tracts of women with gynecologic cancers Int J Cancer 87 2000 824 828
37. D.D. Taylor, C. Gercel-Taylor, and L.P. Parker Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer Gynecol Oncol 115 2009 112 120
38. D.D. Taylor, H.D. Homesley, and G.J. Doellgast "Membrane- associated" immunoglobulins in cyst and ascites fluids of ovarian cancer patients Am J Reprod Immunol 3 1983 7 11
39. D.D. Taylor, H.D. Homesley, and G.J. Doellgast Identification of antigenic components recognized by "membrane-bound" antibodies from ovarian cancer patients Am J Reprod Immunol 6 1984 179 184
40. C. Gercel-Taylor, L.B. Bazzett, and D.D. Taylor Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer Gynecol Oncol 81 2001 71 76
41. J.L. Luborsky, A. Barua, S.V. Shatavi, T. Kebede, J. Abramowicz, and J. Rotmensch Anti-tumor antibodies in ovarian cancer Am J Reprod Immunol 54 2005 55 62
42. C.I. Vidal, P.J. Mintz, K. Lu, L.M. Ellis, L. Manenti, and R. Giavazzi An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients Oncogene 23 2004 8859 8867
43. I. Korneeva, T.A. Caputo, and S.S. Witkin Cell-free 27 kDa heat shock protein (hsp27) and hsp27-cytochrome c complexes in the cervix of women with ovarian or endometrial cancer Int J Cancer 102 2002 483 486
44. A. Olejek, A. Damasiewicz-Bodzek, P. Bodzek, T. Wielkoszynski, J. Zamlynski, and P. Stoltny Concentrations of antibodies against heat shock protein 27 in the sera of women with ovarian carcinoma Int J Gynecol Cancer 19 2009 1516 1520
45. S.R. Chinni, R. Falchetto, C. Gercel-Taylor, J. Shabanowitz, D.F. Hunt, and D.D. Taylor Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients Clin Cancer Res 3 1997 1557 1564
46. B. Liu, J. Nash, C. Runowicz, H. Swede, R. Stevens, and Z. Li Ovarian cancer immunotherapy: opportunities, progresses and challenges J Hematol Oncol 3 2010 7